Impact BioMedical, Inc.
Symbol: IBO (NYSE)
0.59
▼ (-0.19%) -0.001
Company Description:
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Key Stats
- Today's Open: $0.597
- Today's High: $0.597
- Today's Low: $0.584
- Today's Volume: 10.06K
- Yesterday Close: $0.5901
- Yesterday High: $0.6002
- Yesterday Low: $0.574
- Yesterday Volume: 112.30K
- Last Min Volume: 10
- Last Min High: $0.589
- Last Min Low: $0.589
- Last Min VWAP: $0.589
Company Profile
- Name: Impact BioMedical, Inc.
- Website: https://www.impactbiomedinc.com
- Listed Date: 2024-09-16
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001834105
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.19M
- Round Lot: 100
- Outstanding Shares: 12.19M
- Asset Type: CS
RECENT FILINGS FOR IBO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | DEF 14A | View |
| 2025-09-09 | DEF 14C | View |
| 2025-08-25 | PRE 14C | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-05 | DEF 14C | View |
| 2025-07-28 | 8-K | View |
| 2025-07-16 | PRE 14C | View |
| 2025-06-23 | 8-K | View |
| 2025-05-27 | 4 | View |
| 2025-05-14 | 10-Q | View |
| 2025-04-07 | 4 | View |
| 2025-04-07 | 4 | View |
| 2025-04-04 | 4 | View |
| 2025-04-04 | SCHEDULE 13D/A | View |
| 2025-04-03 | 8-K | View |
| 2025-04-02 | SCHEDULE 13D | View |
| 2025-04-02 | 4 | View |
| 2025-03-28 | 4 | View |
| 2025-03-28 | 10-K | View |
| 2025-03-28 | 8-K | View |
Latest News on IBO